Ruth Lehmann grew to become director of the Whitehead Institute for Biomedical Analysis in July 2020. That juncture was deep sufficient into the pandemic for the analysis hub to be steadily reopening after a March 20 shutdown, however the middle affiliated with close by Massachusetts Institute of Know-how remains to be adapting to life with Covid-19. The institute has improved air circulation, made entrances hands-free, added common coronavirus testing for workers, and modified the cafeteria for in-house “takeout” meals. About 80% of scientists have returned to their labs to work in socially distanced shifts, administrative workers largely do business from home, and Lehmann spends a lot of her time in her institute workplace on Zoom calls.
A famous cell biologist who moved her lab from New York College to Cambridge, Mass., Lehmann promotes primary science because the driving power behind the extraordinary advances resulting in quickly developed Covid-19 vaccines. She additionally laments the toll the pandemic has taken on girls in science. In a dialog with STAT, Lehmann charts the institute’s means ahead, explains her personal science, and shares two issues folks may not know concerning the Whitehead. This interview has been condensed and calmly edited.